Grant James Anhalt
#166,438
Most Influential Person Now
Grant James Anhalt's AcademicInfluence.com Rankings
Grant James Anhaltbiology Degrees
Biology
#13508
World Rank
#17056
Historical Rank
Immunology
#935
World Rank
#959
Historical Rank
Neuroscience
#2349
World Rank
#2413
Historical Rank
Download Badge
Biology
Grant James Anhalt's Degrees
- PhD Immunology Stanford University
- Bachelors Biology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Grant James Anhalt Influential?
(Suggest an Edit or Addition)Grant James Anhalt's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes (1994) (1799)
- The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. (2002) (726)
- Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. (1982) (609)
- Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. (1985) (496)
- Paraneoplastic pemphigus. (1990) (491)
- DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis (1995) (441)
- Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. (1994) (439)
- Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. (1993) (367)
- Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. (1990) (342)
- Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. (1998) (288)
- The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). (1989) (266)
- Dry eye and dry mouth in the elderly: a population-based assessment. (1999) (255)
- A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex. (1985) (234)
- Mucous membrane pemphigoid and pseudopemphigoid. (2004) (190)
- Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations. (2004) (189)
- Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. (1985) (185)
- Human autoantibodies against desmoplakins in paraneoplastic pemphigus. (1992) (180)
- Antiepiligrin cicatricial pemphigoid. A subepithelial bullous disorder. (1994) (173)
- Histologic features of paraneoplastic pemphigus. (1992) (163)
- Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. (2003) (163)
- Mycophenolate mofetil in autoimmune and inflammatory skin disorders. (1999) (160)
- Herpes gestationis autoantibodies recognize a 180-kD human epidermal antigen. (1988) (155)
- Drug-induced pemphigus. (1993) (148)
- Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial. (2010) (137)
- Premature termination codons in the type VII collagen gene (COL7A1) underlie severe, mutilating recessive dystrophic epidermolysis bullosa. (1994) (129)
- Pemphigus vulgaris: environmental factors. Occupational, behavioral, medical, and qualitative food frequency questionnaire (2001) (125)
- The mechanism of respiratory failure in paraneoplastic pemphigus. (1999) (122)
- Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus. (1995) (121)
- Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid. (1997) (118)
- Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation. (1992) (115)
- Pemphigus and bullous pemphigoid (1999) (106)
- Immunohistochemical abnormalities of fibrillin in cardiovascular tissues in Marfan's syndrome. (1997) (105)
- Esophageal lichen planus: case report and review of the literature. (2000) (102)
- Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: a retrospective study of 47 patients. (2013) (98)
- Lichenoid dermatitis in paraneoplastic pemphigus: a pathogenic trigger of epitope spreading? (2000) (98)
- Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies. (2007) (97)
- Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis. (1994) (95)
- Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil. (2003) (95)
- Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris. (2003) (92)
- Pemphigus Vulgaris Autoantibody Profiling by Proteomic Technique (2013) (87)
- Defining the role of complement in experimental pemphigus vulgaris in mice. (1986) (86)
- Experimentally induced pemphigus vulgaris in neonatal BALB/c mice: a time-course study of clinical, immunologic, ultrastructural, and cytochemical changes. (1985) (85)
- Paraneoplastic pemphigus presenting as a lichen planus pemphigoides-like eruption. (1993) (85)
- Clinical, demographic, and immunohistologic features of vancomycin-induced linear IgA bullous disease of the skin. Report of 2 cases and review of the literature. (1999) (82)
- Pathogenic effects of bullous pemphigoid autoantibodies on rabbit corneal epithelium. (1981) (81)
- Adalimumab Therapy for Recalcitrant Pyoderma Gangrenosum (2006) (78)
- Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy. (2008) (77)
- Definition of bullous pemphigoid antibody binding to intracellular and extracellular antigen associated with hemidesmosomes. (1989) (74)
- Paraneoplastic pemphigus with clinical features of erosive lichen planus associated with Castleman's tumor. (1995) (71)
- The role of adjuvant therapy in pemphigus: A systematic review and meta-analysis. (2015) (69)
- The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum. (1998) (69)
- Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease. (1999) (67)
- Autoantibodies to desmoplakin I and II in patients with erythema multiforme (1995) (63)
- The Marfan syndrome and the cardiovascular surgeon. (1996) (63)
- Demonstration of pemphigus antibodies on the cell surface of murine epidermal cell monolayers and their internalization. (1984) (61)
- Lichen planus and cicatrizing conjunctivitis: characterization of five cases. (2003) (61)
- Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil. (1999) (61)
- Paraneoplastic pemphigus, pemphigus vulgaris, and pemphigus foliaceus. (1993) (59)
- Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans. (1999) (59)
- Paraneoplastic pemphigus appearing as bullous pemphigoid-like eruption after palliative radiation therapy. (1993) (58)
- Anti-epiligrin cicatricial pemphigoid with antibodies against the gamma2 subunit of laminin 5. (1999) (57)
- Recognition of pemphigus antigens in drug-induced pemphigus vulgaris and pemphigus foliaceus. (1997) (54)
- Oral cyclophosphamide for treatment of pemphigus vulgaris and foliaceus. (2003) (54)
- Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex (1998) (53)
- Paraneoplastic pemphigus: the role of tumours and drugs (2001) (53)
- Research advances in pemphigus (2001) (51)
- Using rituximab (anti-CD20 antibody) in a patient with paraneoplastic pemphigus. (2003) (51)
- Calcium enhances the sensitivity of immunofluorescence for pemphigus antibodies. (1987) (51)
- Pathogenesis of Scleroderma (1984) (50)
- Paraneoplastic pemphigus. (2004) (49)
- Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis. (1986) (49)
- Paraneoplastic pemphigus: a subset of patients with pemphigus and neoplasia (1993) (48)
- CD8+ T lymphocytes in bronchiolitis obliterans, paraneoplastic pemphigus, and solitary Castleman's disease. (2003) (48)
- Induction of acantholysis in organ explant culture by penicillamine and captopril. (1989) (47)
- Studies of the relationship of the 230-kD and 180-kD bullous pemphigoid antigens. (1990) (47)
- Successful therapy for bullous pemphigoid with mycophenolate mofetil. (1998) (47)
- Letters to Dermatology (1998) (46)
- Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus. (2001) (45)
- Envoplakin and periplakin are components of the paraneoplastic pemphigus antigen complex. (1998) (44)
- Making sense of antigens and antibodies in pemphigus. (1999) (42)
- Pemphigoid. Bullous and cicatricial. (1990) (42)
- Elevated serum levels of interleukin-6 in paraneoplastic pemphigus. (1999) (41)
- Systemic sclerosis (scleroderma): clinical, genetic, and serologic subsets. (1987) (40)
- Autoantibodies against desmoplakin I and II define a subset of patients with erythema multiforme major. (1996) (40)
- Paraneoplastic pemphigus: oral involvement as the sole manifestation. (1996) (40)
- Paraneoplastic pemphigus. (1997) (40)
- Ultrastructural studies of acantholysis induced in vivo by passive transfer of IgG from endemic pemphigus foliaceus (Fogo Selvagem). (1989) (38)
- Severe nonendemic pemphigus foliaceus presenting in the postpartum period. (1999) (38)
- Mucosal dominant pemphigus vulgaris with anti-desmoplakin autoantibodies. (2004) (37)
- Serum CA-125 screening for ovarian cancer in patients with dermatomyositis. (1997) (36)
- Bullous and cicatricial pemphigoid. (1991) (36)
- Efficacy of intravenous immunoglobulin (IVIG) affinity‐purified anti‐desmoglein anti‐idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris (2010) (36)
- Specificity and inhibition of the epidermal cell detachment induced by pemphigus IgG in vitro. (1983) (35)
- Effectiveness of infliximab in the treatment of refractory perineal cutaneous Crohn disease. (2000) (35)
- No evidence of human herpesvirus 8 infection in patients with paraneoplastic pemphigus, pemphigus vulgaris, or pemphigus foliaceus. (1998) (35)
- Childhood IgA-mediated epidermolysis bullosa acquisita responding to mycophenolate mofetil as a corticosteroid-sparing agent. (2006) (34)
- High-Dose Cyclophosphamide Without Stem Cell Rescue in 207 Patients With Aplastic Anemia and Other Autoimmune Diseases (2011) (34)
- Vancomycin-Associated Linear IgA Bullous Dermatosis (1998) (33)
- The use of human pemphigoid autoantibodies to study the fate of epidermal basal cell hemidesmosomes after trypsin dissociation. (1985) (31)
- Periplakin and envoplakin are target antigens in canine and human paraneoplastic pemphigus. (1999) (30)
- Evaluating the role of immunoablative high-dose cyclophosphamide therapy in pemphigus vulgaris. (2003) (30)
- Bullous skin diseases. (1995) (29)
- Pemphigus-like eruption from captopril. (1987) (28)
- Mycophenolate in psoralen-UV-A desensitization therapy for chronic actinic dermatitis. (1999) (28)
- Paraneoplastic pemphigus with a pemphigus vegetans-like plaque as the only cutaneous manifestation. (1998) (26)
- Prospects for autoimmune disease: Research advances in pemphigus. (2001) (26)
- Paraneoplastic pemphigus as the presenting symptom of a lymphoma of the tongue. (1998) (25)
- Pernicious anemia and widespread absence of gastrointestinal endocrine cells in a patient with autoimmune polyglandular syndrome type I and malabsorption. (2006) (25)
- Transformation of cutaneous gamma/delta T‐cell lymphoma following 15 years of indolent behavior (2008) (24)
- Rituximab therapy in severe juvenile pemphigus vulgaris. (2007) (24)
- Paraneoplastic Pemphigus: A Case of Long-Term Survival Associated with Systemic Lupus erythematosus and Polymyositis (1999) (24)
- Animal models for bullous pemphigoid. (1987) (24)
- Chronic idiopathic acrocyanosis. (2001) (23)
- Retroperitoneal reticulum cell sarcoma: a cause of paraneoplastic pemphigus. (1993) (23)
- The role of mycophenolate mofetil in the management of pemphigus. (1999) (22)
- Mucosal pemphigus vulgaris anti-Dsg3 IgG are pathogenic to the oral mucosa of humanized Dsg3 mice (2015) (22)
- Bullous pemphigoid treated with leflunomide: a novel immunomodulatory agent. (2000) (22)
- Paraneoplastic pemphigus: A report of two patients responding to cyclosporin (1995) (21)
- Mucous Membrane Pemphigoid of the Vulva (2005) (21)
- Pemphigus and pemphigoid antigens are expressed in human amnion epithelium. (1984) (21)
- Direct immunofluorescence of detached gingival epithelium for diagnosis of cicatricial pemphigoid. Report of five cases. (1993) (21)
- Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid. (1983) (21)
- Drug-induced pemphigus. (1989) (20)
- Inhibition of cutaneous contact hypersensitivity by calcium transport inhibitors lanthanum and diltiazem. (1989) (20)
- Paraneoplastic Pemphigus in a Dog with Splenic Sarcoma (2005) (20)
- Bullous Diseases (2010) (20)
- Pemphigus foliaceus antigen: characterization of a keratinocyte envelope associated pool and preparation of a soluble immunoreactive fragment. (1989) (20)
- Pemphigus vulgaris--a model for cutaneous autoimmunity. (2004) (19)
- Pemphigoid: Bullous, gestational, and cicatricial (1989) (19)
- Vesicular pemphigoid in a 16-year-old boy. (2003) (18)
- Graft-versus-Host-Like Mucocutaneous Eruptions with Serological Features of Paraneoplastic Pemphigus and Systemic Lupus erythematosus in a Patient with Non-Hodgkin’s Lymphoma (1998) (18)
- Cytogenetic survey in systemic sclerosis: correlation of aneuploidy with the presence of anticentromere antibodies. (1993) (17)
- Bullous pemphigoid autoantibodies are markers of corneal epithelial hemidesmosomes. (1987) (17)
- Discoid lupus erythematosus and cicatrizing conjunctivitis: clinicopathologic study of two cases (2002) (17)
- Linear immunofluorescence staining of the cutaneous basement membrane zone produced by pemphigoid antibodies: the result of hemidesmosome staining. (1987) (16)
- An acquired form of epidermolysis bullosa without immunoreactants. Report of a case. (1985) (15)
- Paraneoplastic pemphigus caused by an epithelioid leiomyosarcoma and associated with fatal respiratory failure. (2000) (15)
- The calcium-sensitive epitope of pemphigus foliaceus antigen is present on a murine tryptic fragment and constitutes a major antigenic region for human autoantibodies. (1991) (15)
- Paraneoplastic pemphigus occurring in a patient with B-cell non-Hodgkin's lymphoma. (1998) (15)
- Bullous diseases in the elderly. (2002) (14)
- Disseminated Cellulitic Cryptococcosis in the Setting of Prednisone Monotherapy for Pemphigus Vulgaris (2003) (14)
- Inhibition of Langerhans cell ATPase and contact sensitization by lanthanides--role of T-suppressor cells. (1991) (14)
- Distribution of pemphigus and pemphigoid antigens, laminin, and type IV collagen in corneal epithelium. (1981) (13)
- Developments in Methods for Early Detection of Breast Cancer (1985) (11)
- Nonendemic pemphigus foliaceus presenting as fatal bullous exfoliative erythroderma. (2001) (11)
- The Biological Role of Proteinases and Their Inhibitors in Skin (1988) (10)
- Role of electron microscopy in the diagnosis of ocular mucous membrane pemphigoid. (2006) (10)
- Localization of transforming growth factor-alpha in human appendageal tumors. (1992) (10)
- In vivo studies of antibody dependent acantholysis. (1989) (9)
- Cicatricial pemphigoid. (1993) (9)
- [ATPase positive epidermal Langerhans cells: inhibition of ATPase by ammonium bituminosulfonate (Ichthyol) and pix lithanthracis]. (1992) (8)
- Decreased recognition of paraneoplastic pemphigus in patients previously treated with anti‐CD 20 monoclonal antibodies (2019) (8)
- Paraneoplastic Pemphigus Associated with Pelvic Inflammatory Fibrosarcoma: A Case Report (2005) (7)
- Therapy with oral psoralen plus UV-A for erythema multiforme. (1997) (6)
- Hexamethylene bisacetamide-induced cutaneous vasculitis. (1987) (6)
- The pemphigus antigens. (1983) (5)
- Immunopathology of pemphigus vulgaris, bullous pemphigoid and related bullous dermatoses. (1983) (4)
- Bullous pemphigoid and other basement membrane antigens. (1987) (4)
- Bullous Pemphigoid, Cicatricial Pemphigoid, and Pemphigoid Gestationis (1998) (3)
- Selective surface radioiodination of keratinocytes in primary culture labels a 59 kD keratin and other surface proteins (2004) (3)
- Diffuse bullous eruption in a 3-month-old infant. (1987) (3)
- [Contact hypersensitivity (DNCB test) and inhibition by the calcium channel blocker diltiazem]. (1989) (2)
- Biochemical Acantholysis Provoked by Thiol Drugs-Reply (1990) (2)
- Free Communications: 81st Annual Meeting of the Swiss Society for Dermatology and Venereology (1999) (2)
- Basic pharmacologic approach to immunosuppressive therapy for autoimmune blistering diseases (2002) (2)
- Stimulation of the recruitment of epidermal Langerhans cells by splenopentin (2004) (1)
- Bullous pemphigoid in a patient with systemic sclerosis (scleroderma). (2006) (1)
- Antigenic targets of autoantibodies in canine paraneoplastic pemphigus (1998) (1)
- The Spectrum of Photodamage and its Treatment (1995) (1)
- Perplexing Parlance of Paraneoplastic Pemphigus-Reply (1992) (1)
- Autoimmune bullous diseases (2000) (1)
- (3) Calcium enhances the sensitivity of immunofluorescence for pemphigus antibodies (1988) (1)
- Epidermal proteins. I. Differential extraction and quantitative polyacrylamide gel-electrophoretic analysis of basal spinous-cell proteins of neonatal mouse epidermis (2004) (1)
- Book Review Autoimmune Diseases of the Skin: Pathogenesis, Diagnosis, Management Second edition. Edited by Michael Hertl. 469 pp., illustrated. Vienna, Springer-Verlag, 2005. $129. 3-211-20686-8 (2006) (1)
- Pemphigus (2002) (1)
- Purification of immunoprecipitated pemphigus foliaceus antigen fragment and its use in radioimmunoassay. (1992) (1)
- An acantholytic mucocutaneous disease associated with antibodies against desmoplakins (1998) (1)
- [Immunopathogeny of pemphigus]. (1988) (0)
- Lichen planus esophagitis mimicking intractable erosive esophagitis (2003) (0)
- Clinical Characteristics of Mucous Membrane Pemphigoid and Pseudopemphigoid (2003) (0)
- Animal models. (1983) (0)
- JAMA Peer Reviewers for 2003 (2017) (0)
- Case of the Month: Dermatology (2004) (0)
- Experimental mouse model of pemphigus vulgaris: Passive transfer of desmoglein-targeting antibodies (2003) (0)
- Peer Reviewers 2015 (2015) (0)
- PERPLEXING PARLANCE OF PARANEOPLASTIC PEMPHIGUS. AUTHORS' REPLIES (1992) (0)
- Autoantibodies to epiligrin are a specific marker for a unique form of cicatricial pemphigoid (CP) (1993) (0)
- Autoantibodies and cell-to-cell detachment in pemphigus. (1988) (0)
- S244 Autoantigens of oral epithelium (1997) (0)
- Binding, of fogo selvagem autoantibodies to murine epidermal proteins (1987) (0)
- Psoriasis and skin diseases (WS-055) Chairpersons: Masayuki Amagai, Akira Takashima (2010) (0)
- JAMA Dermatology Peer Reviewers in 2015. (2016) (0)
- Serologic abnormalities in patients with brazilian pemphigus foliaceus ( fogo selvagem ), their relatives and normal donors from endemic and nonendemic regions (1987) (0)
- CHAPTER 17 – Autoimmune Cutaneous Diseases* (1985) (0)
- High Dose Cyclophosphamide (HD CY) without Hematopoietic Stem Cell Transplantation (HSCT) in Refractory Severe Autoimmune Diseases: 11 Year Experience in Over 100 Patients. (2009) (0)
- Desmoglein3 (pemphigus vulgaris antigen) as a major autoimmune target in paraneoplastic pemphigus and its role in pathogenesis (1998) (0)
- Localization of Transforming Growth Factor-ot in Human Appendageal Tumors (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Grant James Anhalt?
Grant James Anhalt is affiliated with the following schools:
